Close Menu
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
What's Hot

King Charles no longer lives at Buckingham Palace after costly renovation, $17 million tax bill revealed

June 25, 2026

Judge blocks President Trump’s rule restricting student loans to graduate students

June 25, 2026

White House asks OpenAI to delay release of new model over safety concerns

June 25, 2026
Facebook X (Twitter) Instagram
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Facebook X (Twitter) Instagram
  • Home
  • AI
  • Art & Style
  • Economy
  • Entertainment
  • International
  • Market
  • Opinion
  • Politics
  • Sports
  • Trump
  • US
  • World
Smart Breaking News on AI, Business, Politics & Global Trends | WhistleBuzz
Home » Stocks that make big moves before the market: AAPL, EL, ROKU, RDDT, RBLX, etc.
World

Stocks that make big moves before the market: AAPL, EL, ROKU, RDDT, RBLX, etc.

Editor-In-ChiefBy Editor-In-ChiefMay 1, 2026No Comments6 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email


Check out the companies with the biggest pre-market moves: Apple — Shares rose 3.5%. In the fiscal second quarter, Apple earned $2.01 per share on revenue of $111.18 billion. That beat analysts’ expectations for earnings of $1.95 a share and revenue of $109.66 billion, according to LSEG. Still, the company’s iPhone sales fell short of expectations for the second time in three quarters. Roku — Streaming stocks soared 7% after Roku posted first-quarter revenue of $1.25 billion, beating expectations of $1.2 billion, according to FactSet. The company’s adjusted EBITDA was $148.4 million, exceeding expectations of $131.3 million. The company also expects adjusted EBITDA, sales and gross profit for the current quarter to exceed analysts’ expectations. Estée Lauder — Shares rose more than 11% after the cosmetics company reported better-than-expected third-quarter sales and raised its full-year forecast. The company had earnings of 91 cents per share on revenue of $3.71 billion, compared to expectations of earnings of 65 cents per share and revenue of $3.69 billion, according to analysts surveyed by FactSet. Estée Lauder also announced plans to make further job cuts as part of its restructuring. Amgen — The biotech stock fell nearly 2% after the company only slightly revised its full-year forecast upward. Amgen expects adjusted earnings to range from $21.70 to $23.10 per share, up from its previous guidance of $21.60 to $23 per share. FactSet’s consensus estimate had called for $22.33 per share. Rivian — The electric car maker’s stock fell nearly 3% despite posting a bigger-than-expected loss in the first quarter. Rivian reported a loss of 33 cents per share and revenue of $1.38 billion. Analysts surveyed by FactSet expected a loss of 63 cents per share on revenue of $1.37 billion. The automaker reaffirmed that it expects to sell between 62,000 and 67,000 cars in 2026. Reddit — The social media platform operator soared more than 13%. Daily active users in the first quarter were slightly higher than expected, coming in at 126.8 million compared to StreetAccount’s consensus estimate of 125.9 million. Adjusted EBITDA for the quarter is expected to be in the range of $285 million to $295 million, compared to the FactSet consensus call of $275.7 million. Moderna — The biotechnology company rose 3% after posting a loss of $3.40 per share in the first quarter, but narrower than expected a loss of $4.45 per share, according to FactSet. Sales also exceeded expectations at $389 million, compared to the expected $236.4 million. Moderna also reaffirmed full-year sales growth of up to 10%. Roblox — The online gaming platform’s stock price plummeted more than 23%. Roblox has lowered its full-year order forecast, now assuming a range of $7.33 billion to $7.6 billion. The previous forecast of $8.28 billion was revised down to $8.55 billion. Second-quarter bookings are expected to range from $1.55 billion to $1.61 billion, compared to expectations of $1.83 billion per LSEG. Paramount Skydance — Shares of the media conglomerate rose 3% after Morgan Stanley upgraded the stock twice from underweight to overweight. The acquisition of Warner Bros. Discovery, cost reductions through artificial intelligence, and increased focus on growing streaming and studio assets bode well for the company’s stock, the bank argued. SanDisk — The memory company fell 4% despite reporting better-than-expected fiscal third-quarter profits. SanDisk had adjusted earnings of $14.54 per share and revenue of $4.75 billion, compared to expectations for adjusted earnings of $23.41 per share and revenue of $5.95 billion, according to analysts surveyed by LSEG. The company also provided better-than-expected guidance, but the stock’s decline comes after it rose more than 360% in 2026. Twilio — Shares rose 22% after the cloud communications software maker reported first-quarter adjusted earnings per share of $1.50, beating the $1.27 expected by analysts surveyed by LSEG. Twilio’s revenue of $1.41 billion also exceeded expectations of $1.34 billion. Meanwhile, the company expects its current quarter revenue to beat TheStreet’s estimates. Clorox — The consumer products company fell 6% after posting a profit beat in its fiscal third-quarter report. Clorox reported earnings of $1.64 per share, compared to analyst estimates compiled by FactSet of $1.55 per share. Sales were in line with expectations at $1.67 billion. But investors were concerned that Clorox would cut its full-year profit outlook as consumers become more selective with their spending amid rising gas prices. Monolithic Power Systems — Shares fell 3% even though the maker of power management semiconductor chips reported better-than-expected first-quarter earnings (excluding items) of $5.10 per share on revenue of $804.2 million. The company also announced that it had won a patent lawsuit brought by Bel Power Solutions. Western Digital — The data storage company’s stock fell 8% despite better-than-expected third-quarter results and fourth-quarter guidance. The company, which recently rebranded to WD, expects adjusted earnings of $3.25 per share, plus or minus 15 cents, for the fourth quarter. Sales were expected to be $3.65 billion plus or minus $100 million. WD stock has soared 74% in the past three months, making it the top performer in the S&P 500 this year. Shares of rival Seagate soared after the company missed profit estimates this week. Dexcom — Shares of the maker of continuous glucose monitoring systems fell 2% despite better-than-expected revenue. Dexcom’s first-quarter earnings were $1.19 billion, or 56 cents per share, excluding items. Analysts had expected revenue of $1.17 billion and earnings of 47 cents per share, according to FactSet. Dexcom reiterated its 2026 revenue estimates of between $5.16 billion and $5.25 billion. The consensus estimate is $5.23 billion. GoDaddy — The website builder soared 3.5% after reporting first-quarter earnings of $1.60 per share on revenue of $1.27 billion. That beat analysts’ expectations for earnings of $1.52 per share and revenue of $1.26 billion, according to FactSet. GoDaddy had free cash flow of $473.6 million in the quarter, beating expectations of $454.2 million. Veeva Systems — Shares soared 11% after the company announced it would join the S&P 500 starting May 7th. Veeva will replace Coterra Energy in the broader index. Cotera stock fell less than 1%. Eastman Chemical — Shares rose nearly 4% after the chemical company earned $1.09 per share excluding items in the first quarter. Analysts polled by FactSet had expected earnings of $1.06 per share. Sales came in at $2.18 billion, slightly exceeding expectations of $2.17 billion. The company noted in a press release that the impact of the Iran war is likely to lead to further earnings upside. AstraZeneca — The UK-based drug company fell more than 1% after an FDA advisory committee voted to reject its new cancer drug. Although the vote is a setback for oral breast cancer treatment, the panelists’ comments leave open the possibility that the drug could be used in other programs. —CNBC’s Christina Cheddar Berk and Darla Mercado contributed reporting.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor-In-Chief
  • Website

Related Posts

Judge blocks President Trump’s rule restricting student loans to graduate students

June 25, 2026

Goolsby of the Chicago Fed says inflation is too high. Williams expects price pressure to ease

June 25, 2026

ON Semi signs $7 billion deal with Synaptics to power physics AI

June 25, 2026
Add A Comment

Comments are closed.

News

Iran accuses NATO of ‘complicity’ in US war: what role did EU countries play? |Commentary news

By Editor-In-ChiefJune 25, 2026

Since the beginning of the US-Israel war against Iran, President Donald Trump has criticized European…

US Supreme Court clears way for government to block asylum seekers at border | Donald Trump News

June 25, 2026

Venezuela earthquake: How will sanctions impact aid efforts? |Earthquake news

June 25, 2026
Top Trending

White House asks OpenAI to delay release of new model over safety concerns

By Editor-In-ChiefJune 25, 2026

The release of OpenAI’s latest model GPT 5.6 will reportedly be different…

Anthropic’s Claude attracts paying consumers, a marketplace owned by ChatGPT

By Editor-In-ChiefJune 25, 2026

Consumers who pay for AI are increasingly choosing Anthropic’s Claude, according to…

Patronus AI raises $50 million to build a “digital world” to stress test AI agents

By Editor-In-ChiefJune 25, 2026

AI agents are becoming increasingly sophisticated. They have evolved from answering questions…

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Welcome to WhistleBuzz.com (“we,” “our,” or “us”). Your privacy is important to us. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://whistlebuzz.com/ (the “Site”). Please read this policy carefully to understand our views and practices regarding your personal data and how we will treat it.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Facebook X (Twitter) Instagram Pinterest
  • Home
  • Advertise With Us
  • Contact US
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
  • About US
© 2026 whistlebuzz. Designed by whistlebuzz.

Type above and press Enter to search. Press Esc to cancel.